Skip to main navigation Skip to search Skip to main content

SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population

Research output: Contribution to journal › Review article › peer-review

Abstract

Reliable antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to uncover the population-wide spread of coronavirus disease 2019 (COVID-19), which is critical for making informed healthcare and economic decisions. Here we review different types of antibody tests available for SARS-CoV-2 and their application for population-scale testing. Biases because of varying test accuracy, results of ongoing large-scale serological studies, and use of antibody testing for monitoring development of herd immunity are summarized. Although current SARS-CoV-2 antibody testing efforts have generated valuable insights, the accuracy of serological tests and the selection criteria for the tested cohorts need to be evaluated carefully.
[Display omitted] Vogl et al. review different types of antibody tests available for SARS-CoV-2 and their application for population-scale testing. Biases because of varying test accuracy, results of ongoing large-scale serological studies, and use of antibody testing for monitoring development of herd immunity are summarized.
Original languageEnglish
Article number100191
Number of pages12
JournalCell Reports Medicine
Volume2
Issue number2
DOIs
StatePublished - 16 Feb 2021

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population'. Together they form a unique fingerprint.

Cite this